CNBC'S UK EXCHANGE NEWSLETTER: HOOKED ON REBATES?
https://image.cnbcfm.com/api/v1/image/108193079-1756818165651-gettyimages-2173105112-ln1_9592_vlmu2qvy.jpeg?v=1756818251&w=1920&h=1080
✍️ The UK pharmaceutical industry is facing a crisis due to the government's decision to increase the rebate rate for branded medicines from 10% to 23%, which has caused friction between the industry and the government.
👉 The UK government has increased the rebate rate for branded medicines from 10% to 23% 👉 The industry body, ABPI, has warned that the new rate will put a 'very real strain' on companies 👉 Industry leaders, including AstraZeneca's CEO, Pascal Soriot, have threatened to move their companies' primary listings to other countries 👉 The crisis has put at risk UK industry growth and investment 👉 The government has faced criticism from industry leaders and experts
-- #PascalSoriot #WesStreeting #JohnMcGinley #DoinaIonescu #JohanKahlström #DonaldTrump #KeirStarmer #AllenSimpson #RachelReeves #London #Cambridge #Oxford #ImperialCollegeLondon #NewYork #U.S. #Europe #Canada #business
Loading quoted post…
